Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Form 8.5 (EPT/NON-RI)

21 Mar 2025 08:36

RNS Number : 6665B
Cavendish Securities PLC
21 March 2025
 

FORM 8.5 (EPT/NON-RI)

  

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cavendish Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tissue Regenix Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Tissue Regenix Group Plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20/03/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD 0.1P

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

92376

 

 

 

 

0.13

 

 

 

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

92376

 

 

0.13

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 0.1P

 

 

 

 

 

 

 

 

Sales

 

15000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

37.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

37.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

21/03/2025

Contact name:

Nancy Dyer

Telephone number:

0207 220 0594

 

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUAOWRVOUOURR
Date   Source Headline
30th Apr 20085:27 pmRNSAudited Final Results
28th Sep 20077:04 amRNSInterim Results
17th Aug 20077:01 amRNSAIM Rule 26 Website
29th Jun 20079:00 amRNSTotal Voting Rights
29th Jun 20078:00 amRNSAccounts to 31 January 2007
29th Jun 20078:00 amRNSAppointment of Directors
25th Jun 20071:38 pmRNSEGM Statement
20th Jun 20077:01 amRNSDisposal & Administration
14th Jun 20074:23 pmRNSRule 8.3- Torex Retail-Amend
13th Jun 20075:34 pmRNSRule 8.3-Torex Retail CB 5.5%
7th Jun 20072:11 pmRNSNotice of EGM
1st Jun 20077:01 amRNSBoard change
17th May 20073:58 pmRNSReview of strategic options
13th Apr 20073:33 pmRNSRule 8.3- Torex Retail Plc
3rd Apr 20072:28 pmRNSRule 2.10 Announcement
30th Mar 20075:03 pmRNSStrategic Review
27th Mar 20075:20 pmRNSHolding(s) in Company
27th Mar 200711:18 amRNSAcquisition
21st Mar 20073:26 pmRNSDirectorate Change
21st Mar 20073:26 pmRNSClarification re. SFO
6th Mar 20077:01 amRNSBoard Changes
26th Feb 20075:04 pmRNSDirectorate Change
23rd Feb 20071:00 pmRNSHolding(s) in Company
16th Feb 20078:21 amRNSHolding(s) in Company
14th Feb 20075:37 pmRNSDirector Deadline
14th Feb 20077:01 amRNSBoard Appt and Bank Funding
8th Feb 20077:00 amRNSBoard Appointments
31st Jan 20075:21 pmRNSManagement Actions
31st Jan 20073:51 pmRNSHolding(s) in Company
30th Jan 20073:27 pmRNSStatement re Torex Retail PLC
26th Jan 20077:30 amRNSTrading Update
26th Jan 20077:30 amRNSSuspension: Torex Retail plc
25th Jan 20077:01 amRNSHolding(s) in Company
23rd Jan 20075:40 pmRNSHolding(s) in Company
22nd Jan 20077:01 amRNSHolding(s) in Company
19th Jan 20074:39 pmRNSTotal Voting Rights
18th Jan 20077:08 amRNSContract with Swarovski
18th Jan 20077:06 amRNSContract Renewal
18th Jan 20077:05 amRNSOutsourcing Contract with IBM
18th Jan 20077:02 amRNSNew Contract Wins
16th Jan 200712:37 pmRNSHolding(s) in Company
29th Dec 200610:42 amRNSTotal Voting Rights
21st Dec 20063:17 pmRNSTotal Voting Rights
7th Dec 20067:01 amRNSHolding(s) in Company
7th Dec 20067:00 amRNSAdditional Listing
5th Dec 20065:06 pmRNSDirector/PDMR Shareholding
4th Dec 20064:52 pmRNSRe OFT
4th Dec 20064:08 pmRNSReview and Restructing
4th Dec 20063:00 pmRNSMerger Update
29th Nov 20064:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.